A noncoding variant confers pancreatic differentiation defect and contributes to diabetes susceptibility by...

Area of Science:

• Genetics
• Endocrinology
• Developmental Biology

Background:

• Noncoding single nucleotide polymorphisms (SNPs) are linked to diabetic traits, but their functional roles remain unclear.
• Understanding the mechanisms by which genetic variants influence diabetes development is crucial for therapeutic strategies.

Purpose of the Study:

• To investigate the functional impact of the noncoding SNP rs6048205 on pancreatic development and diabetes susceptibility.
• To elucidate the molecular mechanisms underlying the association between rs6048205 and diabetes.

Main Methods:

• Analysis of pancreatic progenitor cell differentiation in vitro.
• Investigation of gene expression changes and transcription factor binding (RXRA, FOXA2, NKX6-1).
• Generation and analysis of mouse models carrying the risk variant, including assessment of pancreatic islet architecture and diabetes induction models (streptozotocin, high-fat diet).

Main Results:

• The risk-G variant of rs6048205 impairs the generation of pancreatic progenitor cells (PDX1+/NKX6-1+).
• This variant leads to a decrease in functional beta cells during pancreatic differentiation.
• Mechanistically, the risk-G variant enhances RXRA binding, over-activates FOXA2 transcription, and represses NKX6-1 expression in pancreatic progenitors.
• Overexpression of FOXA2 replicated the differentiation defect.
• Mice with the risk-G variant showed abnormal pancreatic islet architecture and increased susceptibility to chemically induced or diet-induced diabetes.

Conclusions:

• rs6048205 is a causal noncoding variant contributing to diabetes susceptibility.
• The risk-G allele confers a gain-of-function mechanism involving stage-specific transcription factor recruitment.
• This study provides a mechanistic link between a noncoding genetic variant and diabetes development, highlighting the importance of noncoding regions in disease etiology.